JAK Inhibitor_ a concept to utility in the management of Autoimmune Disease by Dr. Puja Srivastava

  • Mechanism of Action: Explores the JAK-STAT signal transduction pathway and its critical role in the pathogenesis of autoimmune diseases.

  • Clinical Efficacy: Reviews clinical trial data and real-world efficacy in treating autoimmune conditions like Rheumatoid Arthritis.

  • Safety & Screening: Highlights safety monitoring protocols, mandatory baseline screening, and risk mitigation strategies.

  • Contraindications & Risk Profiles: Discusses clinical precautions regarding pregnancy, breastfeeding, recurrent infections, venous thromboembolism (DVT/PE risk), and diverticulitis.